Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Liposomal Bupivacaine vs Plain Bupivacaine for Pain Management After Thoracoscopy
NCT03737292Phase 4Recruiting
- Sponsor
- Penn State Health Milton S. Hershey Medical Center
- Start
- Apr 2019
- Primary completion
- Dec 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of liposomal bupivacaine in postoperative pain (2 arms), sponsored by Penn State Health Milton S. Hershey Medical Center. Primary endpoint: Plasma concentration of bupivacaine at 72 hours. Started Apr 2019; status: recruiting.
02
Drugs
liposomal bupivacaine
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT03737292.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03737292.